Connor, Clark & Lunn Investment Management (CC&L)’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-43,582
Closed -$3.29M 1702
2026
Q1
$3.29M Buy
43,582
+6,917
+19% +$520K 0.01% 811
2025
Q4
$2.73M Sell
36,665
-1,540
-4% -$113K 0.01% 838
2025
Q3
$2.58M Buy
+38,205
New +$2.54M 0.01% 780
2024
Q4
Sell
-28,847
Closed -$2.35M 1494
2024
Q3
$2.35M Buy
+28,847
New +$2.31M 0.01% 629
2024
Q2
Sell
-119,156
Closed -$9.29M 1506
2024
Q1
$9.29M Sell
119,156
-176,162
-60% -$13.1M 0.04% 307
2023
Q4
$21.1M Buy
295,318
+36,719
+14% +$2.56M 0.1% 168
2023
Q3
$17.9M Buy
258,599
+215,862
+505% +$16.3M 0.09% 174
2023
Q2
$3.46M Buy
+42,737
New +$3.49M 0.02% 464
2022
Q3
Sell
-29,146
Closed -$2.02M 1167
2022
Q2
$2.02M Buy
+29,146
New +$2.16M 0.01% 465
2020
Q2
Sell
-8,375
Closed -$294K 1090
2020
Q1
$294K Buy
+8,375
New +$399K ﹤0.01% 804
2017
Q4
Sell
-7,325
Closed -$269K 812
2017
Q3
$269K Buy
+7,325
New +$296K ﹤0.01% 717
2017
Q2
Sell
-89,958
Closed -$3.83M 865
2017
Q1
$3.83M Sell
89,958
-165,517
-65% -$6.75M 0.03% 289
2016
Q4
$10.3M Buy
255,475
+132,375
+108% +$5.11M 0.07% 165
2016
Q3
$4.78M Buy
123,100
+73,200
+147% +$2.76M 0.03% 251
2016
Q2
$1.73M Buy
+49,900
New +$1.73M 0.01% 385
2014
Q2
Sell
-12,864
Closed -$305K 580
2014
Q1
$305K Buy
+12,864
New +$278K ﹤0.01% 569

Other funds holding HOLX

Connor, Clark & Lunn Investment Management (CC&L)'s HOLX Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Hologic (HOLX) in Q2 2026, closing a stake of 43,582 shares — an estimated $3.29M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HOLX in Q1 2014 and held it in 16 quarters. The position peaked at $21.1M in Q4 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 43,582 Hologic shares in Q2 2026, an estimated $3.29M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Hologic in Q1 2014 and held it in 16 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Hologic position peaked at $21.1M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.